Antıbody to Inflıxımab ELISA

Enzyme immunoassay for the quantitative and qualitative determination of free antibodies to Infliximab (Remicade®, Remsima®) in serum and plasma.

The solid phase (MTP) is coated by the drug Infliximab. Due to the assay design this test measures the free antibodies which are not bound to Infliximab. Results could be expressed in both qualitative and quantitative manner (nanogram per mililiter-ng/mL).

Reference: IG-BB101

Barcode: 8682754930042

Legal Status: CE-Mark

Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

Related Documents


Quality Control Certificates

Remicade® is a trademark of Janssen Biotech, Inc./Merck & Co.

Remsima® is a trademark of CellTrion Inc.

Required Volume (µL) 50
Incubation Time (min) 135
Sample Serum/Plasma
Package Size 96 Tests
Results in Qualitative & Quantitative (ng/mL)
Shelf Life (years) 2